URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Sandra McDonald

Concepts (176)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Biological Specimen Banks
2
2011
6
1.670
Why?
Carcinoma, Non-Small-Cell Lung
5
1993
72
0.890
Why?
Genomics
1
2012
46
0.820
Why?
Individualized Medicine
1
2011
5
0.810
Why?
Lung Neoplasms
7
1987
439
0.700
Why?
Lung
6
1989
1159
0.490
Why?
Head and Neck Neoplasms
4
1987
83
0.470
Why?
Interferon-beta
2
1993
63
0.430
Why?
Radiotherapy
2
1988
198
0.260
Why?
Radiotherapy Dosage
5
1987
203
0.250
Why?
Amifostine
1
1994
27
0.240
Why?
Salivary Glands
1
1994
65
0.230
Why?
Radiation Injuries
2
1988
131
0.230
Why?
Aryl Hydrocarbon Hydroxylases
1
2013
23
0.220
Why?
Humans
19
1987
36274
0.220
Why?
Genetic Research
1
2012
1
0.220
Why?
Aromatase
1
2012
4
0.210
Why?
Aromatase Inhibitors
1
2012
4
0.210
Why?
Pulmonary Fibrosis
2
1989
140
0.210
Why?
Alleles
1
2013
205
0.210
Why?
Ethics Committees, Research
1
2012
17
0.210
Why?
Genome, Human
1
2012
30
0.210
Why?
Information Dissemination
1
2012
24
0.210
Why?
RNA Splicing
1
2013
142
0.200
Why?
Informed Consent
1
2011
84
0.200
Why?
Quality Assurance, Health Care
1
2012
123
0.190
Why?
Pneumonia
2
1989
196
0.190
Why?
Carcinoma, Squamous Cell
2
1987
236
0.180
Why?
Physician's Role
1
2011
129
0.180
Why?
Drug Resistance, Neoplasm
1
2010
56
0.180
Why?
Laryngeal Neoplasms
1
1989
19
0.170
Why?
Insulin-Like Growth Factor I
1
2010
104
0.170
Why?
Neoplasms, Multiple Primary
1
1989
43
0.170
Why?
Cisplatin
2
1987
95
0.160
Why?
Smoking
1
2012
399
0.160
Why?
Neoplasm Metastasis
1
1987
228
0.140
Why?
Combined Modality Therapy
3
1987
486
0.140
Why?
Antibodies, Monoclonal
1
2010
711
0.140
Why?
Breast Neoplasms
1
2012
673
0.130
Why?
Radiation Pneumonitis
2
1995
44
0.130
Why?
Cystadenocarcinoma, Serous
1
2004
6
0.120
Why?
Cystadenocarcinoma, Papillary
1
2004
10
0.120
Why?
Adenocarcinoma, Clear Cell
1
2004
10
0.120
Why?
Dose-Response Relationship, Radiation
3
1989
219
0.120
Why?
Endometrial Neoplasms
1
2004
37
0.120
Why?
Brachytherapy
1
2004
111
0.110
Why?
Prognosis
4
1987
1083
0.110
Why?
Female
12
1987
19838
0.110
Why?
Exons
2
2012
168
0.100
Why?
Radiation Tolerance
2
1989
89
0.100
Why?
Survival Rate
2
1993
618
0.100
Why?
Recombinant Proteins
2
1993
723
0.090
Why?
Neoplasms
1
1987
739
0.090
Why?
Pilot Projects
2
1987
442
0.090
Why?
Pulmonary Surfactants
2
1989
248
0.090
Why?
Male
8
1988
19675
0.080
Why?
Middle Aged
6
1987
9837
0.080
Why?
Aged, 80 and over
3
1989
2529
0.070
Why?
Feasibility Studies
2
1992
202
0.070
Why?
Aged
5
1989
7269
0.070
Why?
Radiation Dosage
2
1993
125
0.070
Why?
Retrospective Studies
4
1994
2267
0.070
Why?
Antineoplastic Agents
2
2010
619
0.070
Why?
Respiratory Function Tests
1
1995
121
0.060
Why?
Clinical Protocols
1
1995
106
0.060
Why?
Adult
5
1987
11351
0.060
Why?
Fatigue
1
1996
124
0.060
Why?
Sodium Pertechnetate Tc 99m
1
1994
10
0.060
Why?
Secretory Rate
1
1994
42
0.060
Why?
Bronchoalveolar Lavage Fluid
2
1989
303
0.060
Why?
Time Factors
2
1987
3182
0.060
Why?
Radiation Protection
1
1994
23
0.060
Why?
DNA, Neoplasm
1
1994
128
0.060
Why?
Parotid Gland
1
1994
80
0.060
Why?
Antigens, Neoplasm
1
1994
106
0.060
Why?
Follow-Up Studies
2
1987
1855
0.060
Why?
Procollagen
1
1993
11
0.060
Why?
Cesium Radioisotopes
1
1993
29
0.060
Why?
Real-Time Polymerase Chain Reaction
1
2013
24
0.060
Why?
INDEL Mutation
1
2012
1
0.050
Why?
Radiation-Protective Agents
1
1993
41
0.050
Why?
High-Throughput Nucleotide Sequencing
1
2012
6
0.050
Why?
Exome
1
2012
2
0.050
Why?
Genome-Wide Association Study
1
2012
21
0.050
Why?
Radiation-Sensitizing Agents
1
1993
75
0.050
Why?
MAP Kinase Kinase Kinase 1
1
2012
9
0.050
Why?
Molecular Targeted Therapy
1
2012
17
0.050
Why?
MAP Kinase Kinase 4
1
2012
25
0.050
Why?
Mice, Inbred Strains
1
1993
245
0.050
Why?
Nitriles
1
2012
40
0.050
Why?
Respiration
1
1993
181
0.050
Why?
Androstadienes
1
2012
41
0.050
Why?
Mice
3
1993
6111
0.050
Why?
Animals
5
1989
16093
0.050
Why?
Microcomputers
1
1992
10
0.050
Why?
Evaluation Studies as Topic
2
1987
245
0.050
Why?
Triazoles
1
2012
37
0.050
Why?
Radiotherapy, Computer-Assisted
1
1992
15
0.050
Why?
Chromosome Aberrations
1
2012
115
0.050
Why?
Phospholipids
1
1993
181
0.050
Why?
Antineoplastic Combined Chemotherapy Protocols
1
1996
429
0.050
Why?
Genetic Variation
1
2012
151
0.050
Why?
DNA Primers
1
2013
403
0.050
Why?
Cytokines
1
1995
565
0.050
Why?
Point Mutation
1
2012
172
0.050
Why?
Medical Oncology
1
1992
48
0.050
Why?
Receptors, Estrogen
1
2012
178
0.050
Why?
Severity of Illness Index
1
1995
922
0.050
Why?
Sensitivity and Specificity
1
1994
905
0.050
Why?
Clinical Trials as Topic
1
1994
671
0.050
Why?
Clinical Trials, Phase II as Topic
1
2010
13
0.050
Why?
DNA Repair
1
2012
172
0.050
Why?
NIH 3T3 Cells
1
2010
24
0.050
Why?
Tissue Array Analysis
1
2010
35
0.050
Why?
Molecular Diagnostic Techniques
1
2010
11
0.050
Why?
Immunoglobulins, Intravenous
1
2010
36
0.050
Why?
Nuclear Proteins
1
1994
335
0.050
Why?
Gene Expression Profiling
1
2012
301
0.040
Why?
Hormone Antagonists
1
2010
44
0.040
Why?
Pulmonary Surfactant-Associated Proteins
1
1989
27
0.040
Why?
Apoproteins
1
1989
26
0.040
Why?
Radiation Injuries, Experimental
1
1989
90
0.040
Why?
Base Sequence
1
2013
1683
0.040
Why?
Whole-Body Irradiation
1
1989
83
0.040
Why?
Liver
1
2013
877
0.040
Why?
Treatment Outcome
2
1996
2615
0.040
Why?
Radioisotope Teletherapy
1
1987
4
0.040
Why?
Cobalt Radioisotopes
1
1987
17
0.040
Why?
Thoracic Neoplasms
1
1987
19
0.040
Why?
Colorectal Neoplasms
1
1989
137
0.040
Why?
Internship and Residency
1
1992
333
0.040
Why?
Infusions, Intravenous
1
1987
143
0.040
Why?
Lymphatic Metastasis
1
1987
142
0.040
Why?
Mutation
1
2012
1216
0.030
Why?
Palliative Care
1
1987
159
0.030
Why?
Brain Neoplasms
1
1988
281
0.030
Why?
Iridium Radioisotopes
1
2004
15
0.030
Why?
Radiopharmaceuticals
1
2004
48
0.030
Why?
Tomography, X-Ray Computed
1
1988
759
0.030
Why?
Disease-Free Survival
1
2004
198
0.030
Why?
Prostatic Neoplasms
1
1989
555
0.030
Why?
Neoplasm Staging
1
2004
338
0.030
Why?
Magnetic Resonance Imaging
1
1988
991
0.030
Why?
United States
1
1989
2688
0.020
Why?
Brain
1
1988
1214
0.020
Why?
Adolescent
1
1987
4766
0.020
Why?
Etoposide
1
1996
83
0.020
Why?
Radiotherapy, Adjuvant
1
1996
73
0.020
Why?
Chemotherapy, Adjuvant
1
1996
88
0.020
Why?
Antineoplastic Agents, Phytogenic
1
1996
40
0.020
Why?
Treatment Failure
1
1996
128
0.020
Why?
Administration, Oral
1
1996
308
0.020
Why?
Drug Administration Schedule
1
1996
366
0.020
Why?
Platelet-Derived Growth Factor
1
1995
108
0.020
Why?
Ploidies
1
1994
18
0.020
Why?
Autoantigens
1
1994
34
0.020
Why?
Proliferating Cell Nuclear Antigen
1
1994
48
0.020
Why?
Interleukin-1
1
1995
218
0.010
Why?
Fibronectins
1
1995
146
0.010
Why?
Fluorescent Antibody Technique
1
1994
283
0.010
Why?
Collagen
1
1995
290
0.010
Why?
Survival Analysis
1
1996
606
0.010
Why?
Disease Progression
1
1996
521
0.010
Why?
Biopsy
1
1994
362
0.010
Why?
Transforming Growth Factor beta
1
1995
412
0.010
Why?
Predictive Value of Tests
1
1994
606
0.010
Why?
Computer Graphics
1
1992
19
0.010
Why?
Computer-Assisted Instruction
1
1992
20
0.010
Why?
Analysis of Variance
1
1994
736
0.010
Why?
Flow Cytometry
1
1994
603
0.010
Why?
Depression
1
1996
432
0.010
Why?
Mice, Inbred C57BL
1
1995
1675
0.010
Why?
Astrocytoma
1
1988
30
0.010
Why?
Glioblastoma
1
1988
63
0.010
Why?
Rabbits
1
1989
697
0.010
Why?
Biological Markers
1
1989
560
0.010
Why?

Visualizations


McDonald's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department